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Context: To our knowledge, no previous studies examined the longitudinal relationship between
vitamin D status and pulmonary function in a population-based sample of older persons.
Objective:Our objectivewas to examine the cross-sectional aswell as the longitudinal relationship
between vitamin D status and peak expiratory flow rate (PEFR) in a representative sample of the
Dutch older population.
Design, Setting, andParticipants:Participants includedmenandwomen in the LongitudinalAging
Study Amsterdam, an ongoing cohort study in older people.
Main Outcome Measure: PEFR was measured using the mini-Wright peak flow meter.
Results:Menwith serum 25-hydroxyvitamin D (25-OHD) levels below 10 ng/ml (25 nmol/liter) had
a significantly lower PEFR in the cross-sectional analyses, andmenwith serum25-OHD levels below
20 ng/ml (50 nmol/liter) had a significantly lower PEFR in the longitudinal analyses as compared
withmenwith serum 25-OHD levels above 30 ng/ml (75 nmol/liter) (cross-sectional: 47.0, P
0.01 for serum 25-OHD10 ng/ml; longitudinal: 45.0, P 0.01 for serum 25-OHD10 ng/ml;
and   20.2, P  0.03 for serum 25-OHD  10–20 ng/ml in the fully adjusted models). Physical
performance (32.5, P 0.08 for serum 25-OHD10 ng/ml) and grip strength (40.0, P
0.03 for serum 25-OHD 10 ng/ml) partly mediated the cross-sectional associations but not the
longitudinal associations. In women, statistically significant associations between 25-OHD and
PEFR were observed in the cross-sectional analyses after adjustment for age and season of blood
collection but not in the fully adjusted models or in the longitudinal analyses.
Conclusions: A strong relationship between serum 25-OHD and PEFR was observed in older men,
both in the cross-sectional aswell as longitudinal analyses, but not inolderwomen. Theassociation
in men could partly be explained by physical performance and muscle strength. (J Clin Endocrinol
Metab 97: 2164–2171, 2012)
Low vitamin D status has been associated with respira-tory diseases, such as pulmonary tuberculosis (1),
chronic obstructive pulmonary disease (COPD) (2, 3),
asthma (4, 5), and upper respiratory tract infections (6–
8). One of the potential explanations for the observed
association between low vitamin D status and respiratory
tract infections might be a decrease of pulmonary func-
tion. In the literature, only two studies were found exam-
ining the association between serum 25-hydroxyvitamin
D (25-OHD) and pulmonary function in the general pop-
ulation. In the Third National Health and Nutrition Ex-
amination Survey (NHANES III) , a strong cross-sectional
association was found between serum 25-OHD and
forced expiratory volume (FEV1) and forced vital capacity
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(FVC) in adults, but not with FEV1/FVC (9). In the Hert-
fordshireCohort Study, serum25-OHDwasnot related to
FEV1, FVC, or FEV1/FVC in adults (10). To the best of our
knowledge, longitudinal data on vitamin D and pulmo-
nary function are not available in the general population.
Earlier studies showed that vitamin D status was
strongly positively related tomuscle strength and physical
performance tests (11–13). Because pulmonary function
depends onmuscle function, muscle strength and physical
performance will be considered as potential mediators in
the current study.
The present study examines the cross-sectional as well
as the longitudinal relationship between vitamin D status
and peak expiratory flow rate (PEFR) in a representative
sample of the Dutch older population. In addition, the
mediating effects of muscle strength and physical perfor-
mance will be examined. Finally, the optimal cutoff point
for serum 25-OHD in the relationship with PEFR will be
estimated. The following hypotheses will be tested: 1)
lower serum 25-OHD levels are associated with decreas-
ing PEFR, and2) the relationship between serum25-OHD
and PEFR is mediated by physical performance and mus-
cle strength.
Subjects and Methods
Subjects
The Longitudinal Aging Study Amsterdam (LASA) is an on-
going multidisciplinary cohort study on predictors and conse-
quences of changes in physical, cognitive, emotional, and social
functioning in older persons. A random sample of men and
women aged 55 yr and over, stratified by age, sex, urbanization
grade, and expected 5-yr mortality rate was drawn from the
population registers of 11 municipalities in three regions of The
Netherlands. In total, 3107 personswere enrolled in the baseline
examination in 1992–1993 (14). Measurement cycles were re-
peated every 3 yr and included a main interview and medical
interview. For the present study, persons who participated in the
medical interview in 1995/1996 andwere born in or before 1930
(aged 65 yr and older as of January 1, 1996), were selected (n
1509). In 1352 of these persons, blood samples were drawn, and
valid serum25-OHDcouldbedetermined in1320 samples.Data
on serum 25-OHD, PEFR, and covariables were available for
596 men and 611 women in the cross-sectional analyses (1995/
1996) and for 454men and 496women in the longitudinal anal-
yses (1995/1996–1998/1999). The Medical Ethics Committee
(Ethical Review Board) of the VU University Medical Center
approved the study, and all persons gave informed consent.
Peak expiratory flow rate
PEFR is defined as a person’s maximum speed of expiration.
PEFR was measured using the mini-Wright peak flow meter in
1995/1996 and 1998/1999. All subjects received instructions
about the use of the peak flowmeter. For the measurements, the
subjects were asked to take a maximum inspiration and to
breathe out with maximum effort into the peak flow meter. The
highest score of three measurements was used (15).
Serum 25-OHD
Morning blood samples were obtained in 1995/1996. Sub-
jects were allowed to have tea and toast but no dairy products.
The blood sampleswere centrifuged and stored at20C. Serum
25-OHD was determined using a competitive protein binding
assay in 1997/1998 (Nichols Diagnostics, San Juan Capistrano,
CA). The interassay coefficient of variation was 10%. All anal-
yses were performed at the Endocrine Laboratory of the VU
University Medical Center.
Potential effect modifiers
Because of differences in vitamin D status and PEFR between
men andwomen, sexwas identified as a potential effectmodifier
(16, 17).
Potential confounders
Potential confounderswere age, sex (if no interaction effectwas
found),seasonofbloodcollection,education,weight,height, smok-
ing,obstructiveairwaydiseases (asthma, chronicbronchitis, orpul-
monary emphysema), physical activity, and medication use (corti-
costeroids, estrogens, -blockers, or benzodiazepines). Education
level was assessed by asking the respondent for the highest educa-
tion level completed. This was converted into elementary school or
less, secondary school, or higher education. Body height was mea-
sured using a stadiometer. Body weight was measured without
clothes and shoesusingacalibratedbathroombalance scale. Smok-
ing (never/stopped smoking15 yr ago, stopped smoking15 yr
ago, or current smoker) was assessed by self-report. Presence of
obstructiveairwaydiseasewasassessedbyself-report.Activity level
was assessed in minutes per day by the LASA Physical Activity
Questionnaire, a questionnaire covering the following areas: walk-
ing outside, bicycling, gardening, light household activities, heavy
household activities, and amaximumof two sport activities during
the previous 2 wk (18).Medication use was assessed by asking the
respondents to show their medication containers to the interview-
ers. The medication names were recoded into Anatomical Thera-
peutic Chemical (ATC) classification system codes using the ATC
index from the World Health Organization.
Potential mediators
Handgrip strength, an indicator of overall muscle strength
(19), was assessed using a strain-gauged dynamometer (Takei
TKK5001;Takei Scientific InstrumentsCo.Ltd.,Tokyo, Japan).
Participants were asked to perform two maximum-force trials
with eachhand,while standingwith their armalong thebody.To
calculate the total score, themaximumvalues of the right and the
left handwere summed anddivided by two (20). If only one hand
could be used, themaximumvalue of that handwas taken. Phys-
ical performancewas assessed by three tests: time needed towalk
3 m along a line, turn 180°, and walk back (walking test); time
needed to stand up from and sit down on a chair five times with
arms folded across the chest (chair stands test); and the ability to
perform the tandem stand (one foot placed behind the other on
a straight line) for at least 10 sec (13, 21). For thewalking test and
chair stands test, scores one (slowest) to four (fastest) were given
according to the quartile of the distribution of time needed in the
total LASA cohort. Score zero was given to those respondents
who could not complete the test. The tandem stand was catego-
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rized as follows: unable (score 0), able to hold position for 3–9
sec (score 2), and able to hold position for at least 10 sec (score
4). The total physical performance sum score ranged from zero
(low physical performance) to 12 (high physical performance).
Statistical analyses
Vitamin D categories were made using common cutoff points
(serum 25-OHD10, 10–20, 20–30, or30 ng/ml or25, 25–
50, 50–75, or 75 nmol/liter) (22). First, baseline differences
between vitamin D categories were tested. Depending on the dis-
tribution of the variable, differences inmeanwere tested using one-
way ANOVA, differences in median were tested using Kruskal-
Wallis H test, and differences in frequencies were tested using
Pearson 2 test. Second, sex was tested as an effect modifier using
univariable linear regression analysiswith serum25-OHD in dum-
mies (serum 25-OHD10, 10–20, 20–30, or30 ng/ml refer-
ence). Third, the analyses were adjusted for potential confounders.
Physical performance and grip strength were included in separate
models, because these variables could mediate the relationship un-
der study. In the longitudinal analyses, allmodelswere adjusted for
baseline PEFR. The assumptions of linear regression analyses were
checked bymaking histograms and normal probability plots of the
standardized residuals. Multicollinearity was checked by calculat-
ing correlation coefficients between the independent variables.
These were sufficiently low to enter all variables (r 0.4). Fourth,
two sensitivity analyses were performed. First, corticosteroids, es-
trogens,-blockers, andbenzodiazepines, respectively,were added
as confounders to the fully adjusted models in both the cross-sec-
tional as well as the longitudinal analyses. Second, persons having
self-reported obstructive airway diseases at baseline were excluded
fromthe longitudinal analyses.Theaboveanalyseswereperformed
using SPSS version 15.0.1.
Finally, we used restricted cubic spline functions and spline
plots to estimate an optimal cutoff point for serum 25-OHD in
the cross-sectional and longitudinal relationshipwith PEFR.Cu-
bic splines are piecewise polynomial functions that are con-
strained to join smoothly at points called knots. These spline
functions provide better insight into dose-response relationships
compared with analyses using categorized variables. Restricted
cubic spline functions use all data points to estimate the risk at
each level of exposure, as opposed to step functions using cate-
gorical variables,whichassumeaconstant riskwithin categories.
Cubic spline functions were tested in regression models at three
knots using spline plots and likelihood ratio tests. Eventually, the
best fitting spline regression model was identified. All spline re-
gression analyses were performed using R version 2.10.0 (23).
Results
Mean serum 25-OHD was 23.5 ng/ml in men (SD  9.8)
and 19.7 ng/ml in women (SD 9.2). In men, 8.1% had a
serum 25-OHD level below 10 ng/ml, 38.1% below 20
ng/ml, and 75.8%below 30 ng/ml. In women, 13.4%had
a serum 25-OHD level below 10 ng/ml, 56.3% below 20
ng/ml, and 86.9% below 30 ng/ml.
Baseline data are presented in Tables 1 and 2. Men
having lower serum 25-OHD levels were older and had
TABLE 1. Baseline characteristics in men
25-OHD
P value
<10 ng/ml,
n  48
10–20 ng/ml,
n  179
20–30 ng/ml,
n  225
>30 ng/ml,
n  144
Agea 78.8  6.0 77.7  6.8 74.9  6.1 72.2  5.5 0.01
Season (% winter) 64.6 60.9 50.2 50.7 0.06
Education (%)
Less than high school 25.0 31.3 28.0 25.7 0.01
High school graduate 43.8 52.0 61.8 53.5
Postsecondary school 31.3 16.8 10.2 20.8
Heighta 171.2  7.4 172.2  6.6 172.8  6.6 174.6  6.2 0.01
Weighta 76.9  12.8 77.8  11.9 78.5  12.1 78.8  11.3 0.74
Smoker (%)
Never/stopped 15 yr ago 45.8 54.7 54.2 51.4 0.13
Stopped 15 yr ago 14.6 19.0 24.9 25.0
Current 39.6 26.3 20.9 23.6
Obstructive airway diseases (% yes) 22.9 17.3 16.0 13.2 0.44
Corticosteroids (% yes) 2.1 0.6 3.6 0.7 0.10
-blockers (% yes) 16.7 17.9 16.9 13.9 0.81
Benzodiazepines (% yes) 18.8 5.0 6.2 6.3 0.01
Physical activity (min/d)b 95.7 (43.4–165.4) 94.3 (47.1–154.3) 112.0 (69.1–175.6) 121.1 (60.2–177.7) 0.03
Physical performancea 5.6  3.2 7.5  3.0 8.4  2.6 9.0  2.3 0.01
Grip strength (kg)a 30.5  7.1 34.3  7.8 36.4  7.3 38.8  7.9 0.01
PEFR in 1995/1996a 366.7  145.4 414.7  128.8 439.3  122.3 476.0  117.1 0.01
PEFR in 1998/1999a,c 360.0  123.7 422.5  124.5 457.0  123.1 490.8  122.8 0.01
Differences in means were tested using one-way ANOVA, differences in median were tested using Kruskal-Wallis H test, and differences in
frequencies were tested using Pearson 2 test. To convert 25-OHD values from nanograms per milliliter to nanomoles per liter, multiply by 2.496.
a Mean  SD are presented.
b Median (interquartile range) is presented.
c Numbers of persons are 29, 130, 177, and 118 in 25-OHD groups ranging from 25-OHD 10 to 25-OHD 30 ng/ml.
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lower height, less physical activity, lower physical perfor-
mance, lower grip strength, and lower PEFR as compared
with men having higher serum levels. In addition, there
were differences in educational level between different vi-
tamin D groups. Women having lower serum 25-OHD
levels were older, were more often studied in winter, and
had lower height, less physical activity, lower physical
performance, lower grip strength, and lower PEFR as
compared with women having higher serum levels.
An interaction effect between vitamin D status and sex
was observed in the longitudinal analyses (P 0.09 for se-
rum 25-OHD10 ng/ml as compared with 25-OHD 30
ng/ml) but not in the cross-sectional analyses (P0.12). For
comparability reasons, all analyses were stratified for sex.
In Figs. 1 and 2, the unadjusted cross-sectional and lon-
gitudinal associations between serum 25-OHD groups and
PEFR are presented stratified according to sex. In both men
andwomen,ahigherPEFRwasobserved
for higher vitamin D categories.
In Table 3, the cross-sectional and
longitudinal associations between se-
rum 25-OHD and PEFR are presented
in men and women. In men, a strong
relationship between vitamin D status
and PEFR was observed for serum 25-
OHDlevels up to20ng/ml. In the cross-
sectional analyses, this association was
no longer statistically significant for se-
rum 25-OHD levels between 10 and 20
ng/ml in the fully adjusted model (P 
0.13) but remained statistically signifi-
cant for serum25-OHDlevelsbelow10
ng/ml (P  0.01). In the longitudinal
FIG. 1. Cross-sectional association between serum 25-OHD in categories and PEFR. Presented
are the mean and 95% confidence intervals.
TABLE 2. Baseline characteristics in women
25-OHD in women
P value
<10 ng/ml,
n  82
10–20 ng/ml,
n  262
20–30 ng/ml,
n  187
>30 ng/ml,
n  80
Agea 80.6  5.7 76.3  6.3 72.9  5.5 72.1  5.3 0.01
Season (% winter) 68.3 59.5 51.3 47.5 0.02
Education (%)
Less than high school 56.1 53.8 48.1 53.8 0.82
High school graduate 35.4 38.2 44.4 40.0
Postsecondary school 8.5 8.0 7.5 6.3
Heighta 157.1  5.9 160.0  6.9 161.3  6.0 162.4  5.5 0.01
Weighta 69.8  15.4 71.5  13.2 71.4  10.8 69.0  10.8 0.34
Smoker (%)
Never/stopped  5 yr ago 80.5 75.2 80.7 87.5 0.20
Stopped 15 yr ago 4.9 9.9 9.1 6.3
Current 14.6 14.9 10.2 6.3
Obstructive airway diseases
(% yes)
9.8 14.1 9.1 8.8 0.30
Corticosteroids (% yes) 3.7 1.5 3.2 2.5 0.60
Estrogens (% yes) 2.4 1.1 1.6 1.3 0.86
-blockers (% yes) 13.4 16.8 17.1 12.5 0.70
Benzodiazepines (% yes) 28.0 21.0 17.1 13.8 0.09
Physical activity (min/d)b 128.2 (76.8–188.9) 155.0 (103.9–217.2) 172.5 (121.4–240.0) 191.8 (121.1–241.1) 0.01
Physical performancea 4.7  3.1 6.4  3.2 7.9  3.0 8.2  3.0 0.01
Grip strength (kg)a 17.9  4.2 20.8  4.7 22.3  4.7 23.1  4.0 0.01
PEFR in 1995/1996a 293.5  99.3 325.5  97.8 348.9  80.8 372.4  81.0 0.01
PEFR in 1998/1999a,c 302.7  103.9 325.1  98.9 349.8  93.6 369.7  84.2 0.01
Differences in means were tested using one-way ANOVA, differences in median were tested using Kruskal-Wallis H test, and differences in
frequencies were tested using Pearson 2 test.
a Mean  SD are presented.
b Median (interquartile range) is presented.
c Numbers of persons are 56, 208, 160, and 72 in 25-OHD groups ranging from 25-OHD 10 to 25-OHD 30 ng/ml.
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analyses, the relationships remained statistically signifi-
cant up to a serum25-OHD level of 20 ng/ml. Adjustment
for physical performance or grip strength did not change
these results in the longitudinal analyses. However, in the
cross-sectional analyses, the relationship between serum
25-OHD and PEFR was no longer statistically significant
after adding thepotentialmediator grip strength (P0.08
for serum 25-OHD 10 ng/ml). In women, serum 25-
OHD levels below 20 ng/ml were significantly associated
with lower PEFR in the cross-sectional analyses after ad-
justment for age and season. However, the associations
were no longer statistically significant after adding smoking
or height to the model (data not shown) or in the fully ad-
justed model (Table 3). In addition, no
statistically significant associations were
observed after adjustment for potential
mediators or in the longitudinal models.
When adding corticosteroids, estro-
gens, -blockers, and benzodiazepines,
respectively, to the fully adjusted mod-
els, the results were highly similar in
both the cross-sectional as well as the
longitudinal analyses (data not shown).
Persons reporting obstructive airway
diseases at baseline had similar 25-OHD
levels (median  19.5 ng/ml, interquar-
tile range  14.2–27.3) as compared
with persons not reporting obstructive
airwaydiseases (median20.4ng/ml, interquartile range
14.4–27.3). When excluding persons having self-reported
obstructive airway diseases at baseline in the longitudinal
analyses, similar associations were observed. Men having
serum 25-OHD levels below 10 ng/ml showed somewhat
stronger associations (49.9, P 0.01 in the fully ad-
justed model;   48.8, P  0.01 after adjustment for
physical performance;   46.8, P  0.01 after adjust-
ment for grip strength).Menhaving serum25-OHD levels
between 10 and 20 ng/ml showed similar associations
(data not shown). However, these were only borderline
statistically significant (P0.05 in the fully adjustedmod-
FIG. 2. Longitudinal association between serum 25-OHD in categories and PEFR.
TABLE 3. Cross-sectional and longitudinal association between serum 25-OHD and PEFR
25-OHD
Model 1 Model 2 Model 3 Model 4
 (SE) P value  (SE) P value  (SE) P value  (SE) P value
Men
Cross-sectional, n 596
10 ng/ml 73.3 (20.8) 0.01 47.0 (18.1) 0.01 32.5 (18.2) 0.08 40.0 (18.3) 0.03
10–20 ng/ml 30.9 (14.2) 0.03 18.9 (12.3) 0.13 16.3 (12.2) 0.18 16.6 (12.3) 0.18
20–30 ng/ml 21.5 (13.0) 0.10 14.3 (11.3) 0.21 13.6 (11.1) 0.22 13.1 (11.3) 0.25
30 ng/ml Reference Reference Reference Reference Reference Reference Reference Reference
Longitudinal, n 454
10 ng/ml 50.1 (14.8) 0.01 45.0 (14.8) 0.01 43.0 (15.0) 0.01 42.4 (15.1) 0.01
10–20 ng/ml 22.8 (9.3) 0.01 20.2 (9.3) 0.03 19.9 (9.3) 0.03 19.5 (9.3) 0.04
20–30 ng/ml 1.0 (8.4) 0.91 0.2 (8.4) 0.98 0.3 (8.4) 0.97 0.1 (8.4) 0.99
30 ng/ml Reference Reference Reference Reference Reference Reference Reference Reference
Women
Cross-sectional, n 611
10 ng/ml 33.8 (14.6) 0.02 26.1 (14.2) 0.07 18.9 (14.1) 0.18 17.8 (14.1) 0.21
10–20 ng/ml 24.7 (11.3) 0.03 17.1 (11.0) 0.12 13.8 (10.9) 0.21 13.8 (10.9) 0.20
20–30 ng/ml 18.9 (11.5) 0.10 17.7 (11.1) 0.11 17.6 (10.9) 0.11 15.6 (10.9) 0.15
30 ng/ml Reference Reference Reference Reference Reference Reference Reference Reference
Longitudinal, n 496
10 ng/ml 8.3 (12.4) 0.51 12.2 (12.5) 0.33 14.3 (12.5) 0.25 15.4 (12.4) 0.22
10–20 ng/ml 1.0 (9.1) 0.91 0.6 (9.1) 0.95 0.7 (9.1) 0.94 1.0 (9.0) 0.92
20–30 ng/ml 4.3 (9.2) 0.64 1.2 (9.1) 0.90 1.1 (9.1) 0.90 1.6 (9.0) 0.86
30 ng/ml Reference Reference Reference Reference Reference Reference Reference Reference
Model 1 was adjusted for age, season (and baseline PEFR in longitudinal analyses). Model 2 was additionally adjusted for education, height,
weight, smoking, obstructive airway diseases, and physical activity. Model 3 is the same as model 2 and additionally adjusted for physical
performance. Model 4 is the same as model 2 and additionally adjusted for grip strength.
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el; P  0.06 after adjustment for physical performance or
grip strength). In women, no statistically significant associ-
ationswere observed.However, a trend toward significance
was observed after adjustment for physical performance
(P 0.08) or grip strength (P 0.07).
Figure 3 shows the multivariable longitudinal associa-
tionbetween serum25-OHDandPEFR inmen.The spline
plot shows increasing PEFR up to a serum 25-OHD level
of 24 ng/ml (60 nmol/liter). At the lower and higher end of
the spline plot, the confidence interval becomes wider due
to lower numbers of persons having lower or higher 25-
OHD levels. Themultivariable cross-sectional association
between serum 25-OHD and PEFR in men did not show
acutoff point andwasbest fit by a linear function (datanot
shown).
Discussion
Serum25-OHDwas strongly related toPEFR inmen,both
in the cross-sectional as well as in the longitudinal anal-
yses. In the longitudinal analyses, a cutoff point was ob-
served in men at a serum 25-OHD level of 24 ng/ml. In
women, the results were less consistent, showing only sta-
tistically significant results in the cross-sectional analyses.
The resultswere very similarwhen excluding persons hav-
ing self-reported obstructive airway diseases at baseline.
In NHANES III, a strong relationship was found be-
tween serum 25-OHDand FEV1 and FVC in adults (9). In
contrast, in the Hertfordshire Cohort Study, serum 25-
OHDwasnot significantly related toFEV1,FVC,orFEV1/
FVC (10). The latter study did find significant positive
associations between dietary vitamin D intake and FEV1
and FEV1/FVC but not between genotypes of the vitamin
D receptor and lung function (10). According to the au-
thors, the observed associations between dietary vitamin
D intake and lung function may be explained by other
nutrients in the diet that are correlated to dietary vitamin
D. InChinese asthma patients, significant associations be-
tween serum 25-OHD and FEV1 and FEV1/FVC ratio
were observed (24). In addition, in a small study in asthma
patients, serum 25-OHD was positively associated with
FEV1 (25). However, in the Lung Health Study 3 cohort,
baseline 25-OHD levels were not predictive of subsequent
pulmonary function decline in cases (smokers having the
most rapid decline in FEV1) vs. controls (smokers having
the least decline) (26). In patients with COPD, 25-OHD
levels correlated significantly with FEV1 (3).
From the above studies, only NHANES III and the
HertfordshireCohort Studywereperformed in the general
population (NHANES III: aged 20 with 4329 persons
aged 60 yr and over; Hertfordshire Cohort Study: aged
59–73 yr). Although pulmonary function was measured
by PEFR in the current study, our study confirms the re-
sults observed in NHANES III. In both NHANES III and
the Hertfordshire Cohort Study, however, the longitudi-
nal association between serum 25-OHD and pulmonary
function was not examined. In our study, a longitudinal
relationship between serum 25-OHD and PEFR was ob-
served only in men but not in women. The reason for this
is unclear. It may be more difficult to find a statistically
significant result in women, because women showed less
variation in PEFR than men. In addition, women had
lower PEFR values than men, and fewer women reported
obstructive airway diseases at baseline. When excluding
women having obstructive airway diseases at baseline, a
trend toward significance was observed after additional
adjustment for physical performance and grip strength,
respectively.
In the cross-sectional analyses, a statistically significant
lower PEFR was observed in women having serum 25-
OHD levels below 10 ng/ml. This association disappeared
after adjustment for height or smoking. In a systematic
review on sex differences in COPD, it was postulated that
womenmay be more susceptible to COPD thanmen (27).
One of the reasonsmay be that women have smaller lungs
and that these smaller lungs result in a relatively greater
dose of smoke to their lungs as compared with men. This
may explain the large impact of height and smoking on the
association between serum 25-OHD and PEFR in women
in our study. In addition, in women, other factors may be
more important, e.g. a higher genetic susceptibility to de-
velop severe obstruction (27). Future studies are needed to
confirm the interaction effectwith sex and the explanation
FIG. 3. Longitudinal association between serum 25-OHD and PEFR in
men. The dotted line represents 95% confidence interval.
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behind this. In addition, the longitudinal association be-
tween 25-OHD and PEFR in the general population
should be confirmed. In addition to the above analyses, in
our study, the optimal cutoff point for the relationship
between serum 25-OHD and PEFR was examined. Inter-
estingly, the observed cutoff point is similar to the ob-
served cutoff point for the association of 25-OHD with
physical performance (28). It is important to validate the
cutoff point for PEFR in other datasets.
Although several mechanisms have been proposed, it is
not fully understoodhowvitaminDaffects pulmonary func-
tion. In our study, we tested the hypothesis whether the pos-
itive associationbetweenvitaminDandpulmonary function
could be explained by higher muscle strength. With the ex-
ceptionofmenhaving serum25-OHDlevelsbelow10ng/ml
(cross-sectional analyses), adding physical performance or
grip strength to the model did not lead to major changes in
the association between serum 25-OHD and PEFR. Several
othermechanisms have been proposed. First, in vitro studies
revealed that vitamin D modulates the activity of various
defense and immune cells (29). Vitamin D deficiency could
result in altered host defense of the lung with subsequent
growth of abnormal flora that triggers inflammation (29).
High vitamin D-binding protein levels are associated with
lower free vitamin D metabolite levels and may lead to
increased macrophage activation and lower FEV1 (30).
Furthermore, it has been shown thatVDR knockout mice
had increased influx of inflammatory cells, phospho-acet-
ylationofnuclear factor-Bassociatedwith increasedpro-
inflammatory mediators, and up-regulation of matrix
metalloproteinases in the lung (31). This was associated
with emphysema and decline in pulmonary function (31).
These results indicate that absence of the VDR may lead
to an early onset of emphysema, possibly due to inflam-
mation, immune dysregulation, and lung destruction (31).
Second, in a mouse model, it was shown that vitamin D
deficiency decreases pulmonary function. This was pri-
marily explained by a deficit in lung volume and could not
be explained by alterations in somatic growth (32).
Strengths of our study are that LASA is a large repre-
sentative sample of Dutch oldermen andwomen and con-
tains longitudinal data on PEFR. Limitations include that
causality cannot be established within the setting of a co-
hort study, although the observed longitudinal relation-
ship in men does support causality. Second, data on FEV1
and FVC were not available. However, we do think that
PEFR is a valid outcome, because it is an effort-indepen-
dent measure of expiratory flow limitation, which might
play a role in the observed association between vitamin D
status and respiratory tract infections. In addition, PEFR
is related to physical functioning, cognitive functioning,
and mortality (33–35). Third, we did not have data on fat
mass, which may be a more important confounder than
body weight (36). Body weight is a poor predictor of fat
mass and was not related to serum 25-OHD levels in our
study. Finally, we have only self-reported data on obstruc-
tive airwaydiseases andnoobjective assessmentof specific
types of respiratory diseases such as COPD.
In conclusion, a strong relationship between serum 25-
OHD and PEFR was observed in older men, both in the
cross-sectional as well as longitudinal analyses, but not in
older women. This association could partly be explained
by physical performance or muscle strength. Randomized
controlled trials are needed to assess a causal effect of
vitamin D on pulmonary function and respiratory tract
infections.
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